VBI Vaccines
VBIV
$0.58
Share price
2.30%
Change (1 day)
-79.84%
Change (1 year)
Categories
Earnings for VBI Vaccines (VBIV)
Earnings in 2023 (TTM): -$0.12 B
According to VBI Vaccines 's latest financial reports the company's current earnings (TTM) are -$92.84 M. In 2022 the company made an earning of -$0.12 B a decrease over its 2021 earnings that were of -$69.76 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for VBI Vaccines from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.12 B | 0.58% |
| 2022 | -$0.12 B | 62.43% |
| 2021 | -$69.76 M | 50.88% |
| 2020 | -$46.23 M | -15.66% |
| 2019 | -$54.82 M | -13.82% |
| 2018 | -$63.61 M | 61.32% |
| 2017 | -$39.43 M | 57.8% |
| 2016 | -$24.99 M | -67.39% |
| 2015 | -$76.63 M | 1527.36% |
| 2014 | -$4.71 M | 36.21% |
| 2013 | -$3.46 M | -63.91% |
| 2012 | -$9.58 M | -59.19% |
| 2011 | -$23.48 M | 227.23% |
| 2010 | -$7.18 M | 1741.53% |
| 2009 | -$0.39 M | 14.52% |
| 2008 | -$0.35 M | -42.93% |
| 2007 | -$0.6 M | 21.8% |
| 2006 | -$0.49 M | 172.39% |
| 2005 | -$0.18 M | 115.38% |
| 2004 | -$0.09 M | -42.27% |
| 2003 | -$0.15 M | 109.27% |
| 2002 | -$0.07 M | 17.89% |
| 2001 | -$0.06 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | -$18.95 M | -79.59% | 🇺🇸 USA |
 Curis CRIS | -$43.93 M | -52.68% | 🇺🇸 USA |
 Myriad Genetics MYGN | -$0.26 B | 179.31% | 🇺🇸 USA |